CTRI/2021/11/038338招募中不适用
Prospective, Multinational, observational registry utilizing a cloud-based eCRF accessible to investigators. This registry will be open to all physicians managing T2DM, HF or CKD across the world
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 8,500
- 试验地点
- 1
- 主要终点
- 3. Truly global data capture
研究概览
简要总结
This study is to provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Heart Failure and Chronic Kidney Disease
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 99.00 Year(s)（—）
- 性别
- All
入选标准
- •â‰¥18 years old
- •Having type 2 diabetes, CKD and/or HF
- •Providing written informed consent to participate in the study.
排除标准
- •Having any life-threatening co-morbidity and a life expectancy of less than 1 year
- •Participating in any interventional trial requiring informed consent.
结局指标
主要结局
3. Truly global data capture
时间窗: 12 months
1. Data on real-world management of either/or cardiovascular diseases, T2DM and/or CKD
时间窗: 12 months
4. Quality KPIs for benchmarking and improving quality of care
时间窗: 12 months
2. Long-term data collection
时间窗: 12 months
次要结局
- To determine risk factors associated with progression of microvascular and macrovascular disease complications, patient outcomes, loss of quality of life, and increased healthcare resource utilization during follow-up(12 Months)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Lysosomal Acid Lipase (LAL) Deficiency RegistryLysosomal Acid Lipase DeficiencyCholesterol Ester Storage DiseaseWolman DiseaseAcid Cholesteryl Ester Hydrolase Deficiency, Type 2Acid Lipase DeficiencyLIPA DeficiencyLAL-DeficiencyNCT01633489Alexion Pharmaceuticals, Inc.300
已完成
不适用
Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment RegistryPeripheral T-cell LymphomaNCT01110733Acrotech Biopharma Inc.3,000
招募中
不适用
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic DiseasesType 2 DiabetesHypertensionChronic Kidney DiseaseHeart FailureNCT03549754AstraZeneca35,000
已完成
不适用
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic HyponatremiaEuvolemic HyponatremiaHypervolemic HyponatremiaNCT01240668Otsuka America Pharmaceutical5,028
已完成
不适用
Tyvaso Dosing and Titration Evaluation: TyTRATE RegistryPulmonary Arterial HypertensionNCT01799473United Therapeutics98